CLINICAL_TRIALS
trial_result
· 2025-07-01
Clinical Trial Update: RT001 in Amyotrophic Lateral Sclerosis [Phase 2]
Summary
The Phase 2 clinical trial of RT001 for amyotrophic lateral sclerosis has completed. The study is sponsored by Biojiva LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biojiva LLC | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED